Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avadel Pharmaceuticals Plc ADR (NQ: AVDL )

12.60 -0.09 (-0.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 527,650
Open 12.83
Bid (Size) 12.25 (2)
Ask (Size) 13.50 (4)
Prev. Close 12.69
Today's Range 12.56 - 12.89
52wk Range 9.500 - 19.09
Shares Outstanding 96,116,323
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AVDL Stock Earnings: Avadel Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
AVDL stock results show that Avadel Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
On Tuesday, Avadel Pharmaceuticals stock received a positive adjustment to its Relative Strength (RS) Rating, from 76 to 82. 
Via Investor's Business Daily

Performance

YTD
-11.76%
-11.76%
1 Month
-23.45%
-23.45%
3 Month
-12.13%
-12.13%
6 Month
-25.18%
-25.18%
1 Year
+12.80%
+12.80%

More News

Read More
AVDL Stock Earnings: Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
A Preview Of Avadel Pharmaceuticals's Earnings
Via Benzinga
Insiders Buying Dorian LPG And 2 Other Stocks
Via Benzinga
Needham Maintains Buy Rating for Avadel Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 4, 2024
Via Benzinga
Avadel Pharmaceuticals Sees Robust Uptake For Its Newly Approved Sleep Disorder Drug
Via Benzinga
Preview: Avadel Pharmaceuticals's Earnings
Via Benzinga
Where Avadel Pharmaceuticals Stands With Analysts
Via Benzinga
Analyst Expectations for Avadel Pharmaceuticals's Future
Via Benzinga
Analyst Expectations for Avadel Pharmaceuticals's Future
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
What 11 Analyst Ratings Have To Say About Avadel Pharmaceuticals
Via Benzinga
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday
Via Benzinga
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Canopy Growth, Avadel Pharmaceuticals And Other Big Stocks Moving Lower On Friday
Via Benzinga
Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful'
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.